New regulatory pathways may contribute to fibrosis, inflammation, and metabolic dysregulation in AF, as shown by the involvement of MET-LAT1 and the mmu-miR-429-3p/SIRT1 axis. The gene discussed is MET; the disease is atrial fibrillation.